California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

Here's a rundown of some of the multibillion-dollar spending pledges made by companies since President Trump took office. Apple: The iPhone maker pledged to spend more than $500 billion over four ...

People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...

By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...

The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia ...